Please login to the form below

Not currently logged in
Email:
Password:

The Partners

This page shows the latest The Partners news and features for those working in and with pharma, biotech and healthcare.

Novartis forges AI alliance with Oxford University

Novartis forges AI alliance with Oxford University

The two partners say they will use AI and machine learning to find patterns in data – including imaging, genomics, clinical and biological information – which would not be possible by humans alone. ... The alliance also brings in other partners,

Latest news

  • Nektar confirms BMS deal for NKTR-214 is on track Nektar confirms BMS deal for NKTR-214 is on track

    Shares in Nektar rose 10% in the wake of the presentation at JPM healthcare conference. ... Celgene. In an update at the JP Morgan Healthcare conference in San Francisco yesterday, CEO Howard Robin said that the two partners are on track to start two new

  • Sanofi and Regeneron re-jig immuno-oncology deal Sanofi and Regeneron re-jig immuno-oncology deal

    It also includes a termination fee for the other programmes under the original deal, though the partners haven’t clarified which programmes will be discontinued. ... Both are in phase 1 trials as monotherapies and the latter is also being studied in

  • McCann Health announces new global chief creative officer McCann Health announces new global chief creative officer

    He is exactly the kind of global creative leader we need at this moment to continue McCann Health’s growth and commitment to do meaningful work for our brand partners.”. ... befitting their reputation as one of the world’s most awarded global

  • Horizon Discovery and C4X to harness CRISPR for new cancer drugs Horizon Discovery and C4X to harness CRISPR for new cancer drugs

    The partners aims to validate novel targets identified by Horizon against ‘synthetic lethality’ – a mechanism proven to be clinically and commercially successful by the poly(ADP-ribose) polymerase (PARP) inhibitors, led ... The partners will work

  • FDA takes aim at pharma’s biosimilar-delaying tactics FDA takes aim at pharma’s biosimilar-delaying tactics

    anti-competitive behaviour,” said Gottlieb, warning: “We’re not going to be partners to these deceptions.”. ... At the moment insulins are regulated in the same way as small molecule drugs.

More from news
Approximately 1 fully matching, plus 546 partially matching documents found.

Latest Intelligence

  • Lonely planet: why there is dwindling value in pharma travelling alone Lonely planet: why there is dwindling value in pharma travelling alone

    In the process, the focus on demonstrating value has now reached fever pitch. ... The value story. Beyond finding the right partners to unlock a clear understanding of shared value, one of the biggest challenges the industry faces is around how it

  • Joint working that works Joint working that works

    The reality, however, is often disappointing and many joint working initiatives fail to deliver. ... The set-up phase should include taking a holistic view and looking to understand the challenges and perspectives of all the partners.

  • China: AstraZeneca’s new engine for growth and innovation China: AstraZeneca’s new engine for growth and innovation

    AstraZeneca has taken advantage of this by working closely with provincial and municipal government partners, which include Shanghai and Pudong, Nanjing, Wuxi and Taizhou. ... We’re working with a cross section of partners from the government, industry,

  • Cannes Lions Healthcare Agency of the Year – championing change and demanding more… Cannes Lions Healthcare Agency of the Year – championing change and demanding more…

    Brilliant, empathetic, vulnerable; creatives. The spiritual partners to stakeholders across healthcare that deny tradition, champion change and. ... Unpaid carers are the glue that holds healthcare systems together. To doctors they are the partners

  • Trust me, I’m from pharma Trust me, I’m from pharma

    So how is pharma trying to repair the damage of yesterday’s behaviours? ... This fundamentally changes the relationships companies have with their customers; by taking ownership of a broader set of outcomes and aligning incentives more effectively,

More from intelligence
Approximately 0 fully matching, plus 74 partially matching documents found.

Latest appointments

  • Dr Martin Rothman joins Sofinnova Partners Dr Martin Rothman joins Sofinnova Partners

    Rothman brings 40 years of experience along with an international network in the medical field to Sofinnova Partners. ... Commenting on the appointment, Antoine Papiernik, managing partner and chairman of Sofinnova Partners, said: “Martin is an

  • Unlimited Group appoints group managing director Unlimited Group appoints group managing director

    Richards joins the group from VCCP, where he held the role of international managing director. ... Richards will head the group’s partners’ board and will report into the group Chairman Ian Ferguson.

  • PureTech Health appoints new chief financial officer PureTech Health appoints new chief financial officer

    Joep Muijrers joins the biopharma from Life Sciences Partners. Clinical-stage biopharmaceutical company PureTech Health has bolstered the team with a new chief financial officer in the form of Joep Muijrers. ... Muijrers most recently served as a partner

  • Professor Carole Longson moves from NICE to the ABPI Professor Carole Longson moves from NICE to the ABPI

    and the role our members play in developing new innovative medicines and vaccines. ... experience, expertise and network in both industry and academia will enable the ABPI to work with our partners to further these objectives.”.

  • Lexington Communications bolsters team with a trio of new-hires Lexington Communications bolsters team with a trio of new-hires

    of the ever-changing health landscape to provide invaluable strategic advise and insider analysis to our existing and potential clients.”. ... Our new senior advisors will join a team that has the reputation of being one of the best in the market, and

More from appointments
Approximately 1 fully matching, plus 24 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 61 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Complete HealthVizion

Complete HealthVizion is a global team of fresh thinkers who aspire to be better every day. We create life-changing medical...

Latest intelligence

Alzheimer’s disease – is Europe prepared if a breakthrough treatment becomes available?
Healthcare leaders in the European Union should begin preparing for a breakthrough now...
The UK’s new five-year pricing agreement
Pharma has agreed to capped growth again - in exchange for uptake promises...
Digital applications are transforming the market access landscape
Organisations are leveraging new technology to implement a wider range of business models and, in essence, drive market access success by working smarter, faster and with greater economy....

Infographics